Detection of Pro- and Anti-Inflammatory Cytokines in Stools of Patients with Inflammatory Bowel Disease

References

• Podolsky DK. Inflammatory bowel disease. I. N Engl J Med 1991;325:928–37.
   PubMed Web of Science ®Google Scholar
• Fiocchi C. Cytokines. In: Targan SR, Shanahan F, editors. Inflammatory bowel disease: from bench to bedside. Baltimore: Williams & Wilkins; 1994. p. 106–22.
   Google Scholar
• Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994;106: 533–9.
   PubMed Web of Science ®Google Scholar
• Reinecker H-C, Schreiber S, Stenson WF, MacDermott RP. The role of the mucosal immune system in ulcerative colitis and Crohn’s disease. In: Ogra PL, StroberW, Mestecky J, McGhee JR, Lamm ME, Bienenstock J, editors. Handbook of mucosal immunology: San Diego (CA): Academic Press; 1994. p. 439–56.
   Google Scholar
• Stevens C, Walz G, Singaram C, Lipman ML, Zanker B, Muggia A, et al. Tumor necrosis factor-α, interleukin-1β, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 1992;37:818–26.
   PubMed Web of Science ®Google Scholar
• Isaacs KL, Sartor RB, Haskill S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992;103:1587–95.
   Google Scholar
• Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott RP, et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn’s disease. Clin Exp Immunol 1993;94:174–81.
   PubMed Web of Science ®Google Scholar
• Niessner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (Rt-PCR). Clin Exp Immunol 1995;101: 428–35.
   Google Scholar
• Van Dullemen HM, Van Deventer SJH, Hommes DW, Bijl HA, Jansen J, Tytgat GNJ, et al. Treatment of Crohn’s disease with anti-tumor-necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995;109:129–35.
   PubMed Web of Science ®Google Scholar
• Schreiber S, Heinig T, Thiele HG, Raedler A. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 1995;108:1434–44.
   PubMed Web of Science ®Google Scholar
• Braegger CP, Nicholls S, Murch SH, Stephens S, MacDonald TT. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 1992;339:89–91.
   Google Scholar
• Nicholls S, Stephens S, Braegger CP, Walker-Smith JA, Macdonald TT. Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea. J Clin Pathol 1993; 46:757–60.
   Google Scholar
• Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 1955;2:1041–8.
   Web of Science ®Google Scholar
• Matts SGF. The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med 1961;120:393–407.
   Google Scholar
• Myren J, Bouchier IAD, Watkinson G, Softley A, Clamp SE, de Dombal FT. The O.M.G.E. multinational inflammatory bowel disease survey 1976–1982. A further report on 2,657 cases. Scand J Gastroenterol 1984;19 Suppl 95:1–27.
   Google Scholar
• Raqib R, Wretlind B, Andersson J, Lindberg AA. Cytokine secretion in acute shigellosis is correlated to disease activity and directed more to stool than to plasma. J Infect Dis 1995;171: 376–84.
   PubMed Web of Science ®Google Scholar
• Raqib R, Lindberg AA, Björk L, Bardhan PK, Wretlind B, Andersson U, et al. Down-regulation of gamma interferon, tumor necrosis factor type 1, interleukin 1 (IL-1) type 1, IL-3, IL-4, and transforming growth factor β type 1 receptors at the local site during the acute phase of shigella infection. Infect Immunol 1995;63: 3079–87.
   Google Scholar
• Hirao J, Hibi S, Andoh T, Ichimura T. High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease. Int Arch Allergy Immunol 1997;112:152–6.
   PubMed Web of Science ®Google Scholar
• Howard M, O’Garra A, Ishida H, de-Waal-Malefyt R, de-Vries J. Biological properties of interleukin 10. J Clin Immunol 1992;12: 239–47.
   Google Scholar
• Adeyemi EO, Hodgson HJF. Faecal elastase reflects disease activity in active ulcerative colitis. Scand J Gastroenterol 1992; 27:139–42.
   PubMed Web of Science ®Google Scholar
• Mahida YR, Wu K, Jewell DP. Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn’s disease. Gut 1989; 30:835–8.
   Google Scholar
• Mitsuyama K, Sasaki E, Toyonaga A, Ikeda H, Tsuruta O, Irie A, et al. Colonic mucosal interleukin-6 in inflammatory bowel disease. Digestion 1991;50:104–11.
   PubMed Web of Science ®Google Scholar
• Mitsuyama K, Toyonaga A, Sasaki E, Watanabe K, Tateishi H, Nishiyama T, et al. IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn’s disease. Clin Exp Immunol 1994;96:432–6.
   PubMed Web of Science ®Google Scholar
• Nishiyama T, Mitsuyama K, Toyonaga A, Sasaki E, Tanikawa K. Colonic mucosal interleukin 1 receptor antagonist in inflammatory bowel diseae. Digestion 1994;55: 368–73.
   Google Scholar
• Casini-Raggi V, Kam L, Chong YJT, Fiocchi C, Pizarro TT, Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. J Immunol 1995;154: 2434–40.
   Google Scholar
• MacDonald TT, Hutchings P, Choy MY, Murch S, Cooke A. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 1990;81:301–5.
   Google Scholar
• Nielsen OH, Køppen T, Rudiger N, Horn T, Eriksen J, Kirman I. Involvement of interleukin-4 and -10 in inflammatory bowel disease. Dig Dis Sci 1996;41:1786–93.
   PubMed Web of Science ®Google Scholar
• Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN-y, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996;157: 1261–70.
   Google Scholar
• Radford-Smith G, Jewell DP. Cytokines and inflammatory bowel disease. Baillieres Clin Gastroenterol 1996;10:151–64.
   PubMed Web of Science ®Google Scholar
• Dinarello CA, Thompson RC. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today 1991; 12:404–10.
   PubMedGoogle Scholar
• Beutler B, Cerami A. The biology of cachectin/TNF—a primary mediator of the host response. Annu Rev Immunol 1989;7:625–55.
   PubMed Web of Science ®Google Scholar
• Hart PH, Vitti GF, Burgess DR, Whitty GA, Piccoli DS, Hamilton JA. Potential antiinflammatory effects of interleukin-4: Suppression of human monocyte tumor necrosis factor a, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci USA 1989;86:3803–7.
   PubMed Web of Science ®Google Scholar
• Vannier E, Miller LC, Dinarello CA. Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc Natl Acad Sci USA 1992;89: 4076–80.
   Google Scholar
• Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147: 3815–22.
   Google Scholar
• Howard M, O’Garra A. Biological properties of interleukin 10. Immunol Today 1992;13:198–200.
   PubMedGoogle Scholar
• Zimmerman MJ, Jewell DP. Cytokines and mechanisms of action of glucocorticoids and aminosalicylates in the treatment of ulcerative colitis and Crohn’s disease. Aliment Pharmacol Ther 1996;10:93–8.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993;14:436–41.
   PubMed Web of Science ®Google Scholar
• Eckmann L, Jung HC, Schürer-Maly C, Panja A, Morzycka- Wroblewska E, Kagnoff MF. Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. Gastroenterology 1993;105: 1689–97.
   Google Scholar